CBD:THC Ratios Show Neuroprotection in Brain Injury Study – CED Clinic
Emerging research on CBD THC ratios for brain injury neuroprotection reveals promising preclinical mechanisms, though human clinical translation remains early-stage. Understanding cannabinoid synergy and realistic therapeutic expectations guides…
GLP-1 Receptor Agonist Clinical Evidence: FGF15 Insights
FGF15 metabolic adaptation plays a key role in how patients respond to GLP-1 receptor agonist therapy. This gut hormone influences weight loss mechanisms beyond appetite suppression. Understanding FGF15 helps explain variability in treatment outcomes and…
CBD and Colon Cancer: A Promising Hypothesis Built on Preclinical Ground
By influencing the serotonergic system, CBD colorectal cancer serotonergic pathway may confer both protective and potentially deleterious effects during CRC development. This 2025 review synthesizes preclinical evidence without human clinical trials. The…
Mouse Study on Prenatal Cannabinoid Effects on Fetal Brain Vasculature
This mouse study investigates prenatal cannabinoid fetal brain effects, showing reduced blood flow in fetal brain vasculature. The research used a synthetic cannabinoid with dose-related vessel diameter reductions. However, human relevance remains…
Study: Minor Cannabinoids Show Distinct Effects on Pain-Sensing Neurons
Minor cannabinoids pain management research highlights their distinct effects on pain-sensing neurons. These compounds may offer new therapeutic options beyond THC and CBD. Understanding their role is crucial for advancing cannabinoid therapies.
Cannabinoid Pain Relief: Sodium Channel Modulation Research
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve transmission, based on laboratory evidence from multiple studies. This mechanism may explain part of cannabinoids' pain-relieving effects, though…
Unpredictable Chronic Mild Stress Upregulates Dopamine Receptor Expression Independent of FABP7
This study investigates chronic mild stress dopamine receptor expression and its independence from FABP7 gene deletion. Findings reveal increased dopamine receptor levels under stress regardless of FABP7 status. Understanding chronic mild stress dopamine…
Exploring cannabinoid receptor CB1 autophagy and the obesity phenotype of p62-deficient mice.
The endocannabinoid system (ECS) and the autophagy receptor p62 are both implicated in metabolic regulation and obesity, yet the mechanisms linking these pat...
Evaluating FABP5 as a Therapeutic Target for Pain Management.
FABP5 pain management is emerging as a promising non-opioid approach to analgesia. Pharmacological inhibition of FABP5 shows analgesic effects in preclinical pain models. This target modulates cannabinoid receptor signaling, offering new insights into…
Distribution and Modulation of Endocannabinoid Enzymes in Post-Traumatic Headache
Post-traumatic headache endocannabinoid system changes are critical in understanding pain after mild traumatic brain injury. This study maps enzyme distribution in trigeminal and midbrain regions. Findings provide a foundation for potential…